SavedAdd your journal

Journals / Osteoporoz Dünyasından / 2003 / Cilt: 9 - Sayı: 4

Comparison of different treatment protocols in osteoporosis

Osteoporozda değişik tedavi protokollerinin karşılaştırılması

Ali AYDENİZ
Mustafa GÜLER
Ö. Faruk ŞENDUR
Pages
146–149
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result we concluded that patients choice, side effects and cost must be regarded for drug preference.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study was to compare the effectiveness of different medical treatment protocols in osteoporosis.
📊
Key Findings & Data:For this purpose 153 postmenopausal women who were diagnosed as osteoporosis were randomly divided into 4 groups and given different medical treatments for 1 year period.
💡
Conclusion & Impact:As a result we concluded that patients choice, side effects and cost must be regarded for drug preference.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kemik yoğunluğu · Osteoporoz · Klinik protokoller

Abstract

The aim of this study was to compare the effectiveness of different medical treatment protocols in osteoporosis. For this purpose 153 postmenopausal women who were diagnosed as osteoporosis were randomly divided into 4 groups and given different medical treatments for 1 year period. Before and after the treatment bone mineral density was measured . Bone mineral density increased in all 4 groups after treatment. But increament in the groups was not statistically different from each other. As a result we concluded that patients choice, side effects and cost must be regarded for drug preference.

Özet

Bu çalışmada amacımız osteoporoz tedavisinde kullanılan değişik tedavilerin etkinliğini karşılaştırmaktı. Bu nedenle postmenopozal osteoporoz tanısı almış 153 hasta 4 gruba ayrıldı ve 4 farklı tedavi seçeneği 1 yıl süre için uygulandı. Tedavi öncesi ve sonrası kemik mineral yoğunluğu DEXA yöntemi ile ölçüldü. 4 grupta da kemik mineral yoğunluğunda artma saptandı. Gruplar arasında anlamlı fark bulunmadı. Bu nedenle hastanın tercihi, yan etkiler ve maliyetin ilaç seçiminde yönlendirici etkisi olduğu kanısına vardık.

🔖

Cite This Article

AYDENİZ, A., GÜLER, M., ŞENDUR, Ö. F. (2003). Comparison of different treatment protocols in osteoporosis. Osteoporoz Dünyasından, Cilt: 9 - Sayı: 4, 146–149. https://ajindex.com/articles/286793

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Eryavuz-Sarıdoğan M. Osteoprozun tanımı ve sınıflaması. In:Gökçe-Kutsal Y.(ed) Modern Tıp Seminerleri: 19. Osteoporoz. Ankara, Güneş Kitabevi, 2001;1-5
  2. Michele R. Davidson CNM. Pharmacotherapeutics for osteoporosis prevention and treatment. J Midwifery Women's Health 2003;48:39-52
  3. Kado DM, Browner WS, Palermo L, et al. Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med 1999;159: 1215-1220
  4. Ensrud KE, Thompson DE, Cauley JA, et al. Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc 2000; 48:241-249
  5. Michael R. McClung MR. Prevention and management of osteoporosis. Best Pract Res Clin Endocrinol Metab 2003;17: 53-71
  6. Rodríguez-Martínez MA, García-Cohenb C. Role of Ca2+ and vitamin D in the prevention and treatment of osteoporosis. Pharmacology & Therapeutics 2002;93:37-49
  7. Dequeker J, Gregory RM. Management of osteoporosis. In: Klippel JH, Dieppe PA (eds) Rheumatology 2nd ed. London Mosby 1998:8.39.1 8. Heaney RP. Effect of calcium on skeletal development, bone loss and risk of fractures. Am J Med 1991;91:23-28
  8. Reid IR. Osteoporosis: Non-HRT treatments. Reviews in Gynaecological Practice 2002;2:48-53
  9. Riggs BL, Ofallon WM, Muhs J, et al. Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res 1998;13:168-174
  10. Delmas PD. Treatment of postmenopausal osteoporosis. The Lancet 2002;359:2018-2026
  11. Kanis JA. Calcitonin in osteoporosis. Bone 2002;30:65-66
  12. Bodya JJ. Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis. Bone 2002;30:75-79
  13. Gennari C, Chierichetti SM, Bigazzi S, et al. An effective regimen of intranasal salmon calcitonin in early postmenopausal bone loss. Calcif Tissue Int 1992;50:381-383
  14. Thamsborg G, Storm TL, Sykulski E, et al. Effect of different doses of salmon calcitonin on bone mass. Calcif Tissue Int 1991;48:302-307
  15. Ellerington MC, Hillard TC, Whitcrowd SIJ, et al. Intranasal salmon calcitonin for prevention and treatment of postmenopausal osteoporosis. Calcif Tissue Int 1996;59:6-11
  16. Pols HA, Felsenberg D, Hanley DA,et al. Multinational placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low b